Financial Statements

AngioDynamics, Inc. (ANGO)

$5.7

+0.30 (+5.56%)

Balance Sheet Statement

All numbers are in thousands
Year XLSX
2023
XLSX
2022
XLSX
2021
XLSX
2020
XLSX
2019
Total assets 532,637552,751561,438595,512836,438
Total Current Assets 163,542143,345140,879152,913315,292
Cash and Short Term Investments 44,62028,82548,16154,435227,641
Cash and cash equivalents 44,62028,82548,16154,435227,641
Short Term Investments ---689-
Receivables 52,82652,30435,40531,26343,577
Inventory 55,32551,39248,61459,90540,071
Other Current Assets 4,6172,2011,7602,2382,203
Total non-current Assets 369,095409,406420,559442,599521,146
Property, Plant & Equipment Net 44,38445,00537,07328,31224,258
Goodwill and Intangible Assets 270,382353,438370,293398,651493,053
Goodwill 270,382353,438370,293398,651493,053
Intangible Assets 111,144152,380168,977197,136145,387
Long Term Investments -12,813--19,955-24,057-14,542
Other non-current Assets 54,329-5,07413,19315,6363,835
Total liabilities 154,341128,262121,981139,640221,623
Total current liabilities 83,82574,32457,58451,53473,302
Payables 40,44528,04719,63019,09622,829
Short Term debt 14,7618,7832,41583612,135
Deferred revenue -14,76116,037-2,41529,469-
Other Current Liabilities 43,38021,45737,9542,13338,338
Total non-current liabilities 70,51653,93864,39788,106148,321
Long Term debt 49,81825,00020,00040,000124,407
Other non-current Liabilities 7,88512,90124,44224,0499,372
Total shareholders equity 378,296424,489439,457455,872614,815
Common Stock 382380377374372
Retained earnings -210,855-158,413-131,866-100,31866,469
Accumulated Other Comprehensive Income Loss -4,7231,3573,153-1,341-1,352
Other Stockholders Equity 593,492581,165567,793557,157549,326
Total debt 49,81833,78320,00040,836136,542
Total Investments -12,813--19,955-24,057-14,542
Net Debt 5,1984,958-28,161-13,599-91,099

AngioDynamics, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes AngioDynamics, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.